Global Bronchoscopes Market By Product Type (Rigid Bronchoscope, Flexible Bronchoscope), By Usage (Reusable Bronchoscope and Disposable Bronchoscope), By End User (Hospitals, Diagnostic Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

In 2022, the Global Bronchoscopes Market was valued at USD 2.8 Bn. Between 2023 and 2032, this market is estimated to reach USD 7.0 Bn registering at the highest CAGR of 9.9% during the forecast period.

Numerous respiratory and airway diseases can be evaluated and treated with bronchoscopes. Bronchoscopes are used by doctors to check the airways. A bronchoscope is a device with a thread that goes through the mouth or nose and into the lungs. Blockages, COPD, bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions can all be detected by these devices.

To view distal bronchial branches, bronchoscopes are inserted through the mouth, nose, or sometimes through a tracheostomy. A rigid bronchoscope may be required if there is blood in the lungs or a large object blocking the airway. The prevalence of respiratory diseases, improved reimbursement policies, and technological advancements have all contributed to an increase in bronchoscope demand. Moreover, the most significant factor favouring market expansion is the rising incidence of various respiratory diseases.

*Actual Numbers Might Vary In The Final Report

Market Key Takeaways

• Market Developments: The market for bronchoscopes has experienced steady expansion due to rising respiratory disease incidence rates and demand for innovative diagnostic and treatment tools.
• Diagnostic and Therapeutic: Bronchoscopes offer physicians a way to visualize and treat airway and lung conditions through diagnostic imaging technology.
• Endoscopy Advancements: Technological advancements have resulted in slim, flexible bronchoscopes with improved maneuverability and image quality that provide endoscopic imaging services.
• Respiratory Disease Prevalence: Rising rates of chronic obstructive pulmonary disease (COPD), lung cancer and other respiratory ailments is driving up demand for bronchoscopic procedures.
• Cancer Diagnosis: Bronchoscopes play an invaluable role in early diagnosis and staging of lung cancer – one of the leading causes of death related to cancer worldwide.
• Infection Control: Implementing proper sterilization and infection control practices when conducting bronchoscopie is paramount to avoiding healthcare-associated infections.

Product Type Analysis

The flexible bronchoscope segment dominated the market in 2022

Based on Product type, the market for Bronchoscopes is segmented into rigid bronchoscopes, flexible bronchoscopes, and other product types. The market is expected to expand significantly during the forecast period, with the segment of flexible bronchoscopes accounting for the largest share. There is video, fiberotrophic, and hybrid flexible bronchoscopes available. The flexible market segment generated the highest revenue because of its low prices and the high quality of the video.

The fiberoptic subsegment has dominated the flexible segment due to its numerous advantages, such as high-quality videos that make tumors and infections in deeper bronchioles easy to identify. Patients and doctors are likely to benefit from flexible bronchoscopes. Rigid bronchoscopy takes longer to recover than flexible bronchoscopy. Hence, flexible bronchoscopes are preferred over rigid bronchoscopes. Small lumens can be penetrated deeper with these narrow devices.

Usage Analysis

The Reusable bronchoscope segment is anticipated to grow at a significant CAGR during the forecast period

By Usage, the market is further divided into reusable bronchoscopes and disposable bronchoscopes. The market’s largest contributor is the reusable category, which is anticipated to expand at a CAGR of 10.1% over the forecast period. Between uses, soil, and contaminants are removed during reprocessing, and microorganisms are sterilized or disinfected. Guidelines for using single-use flexible bronchoscopes (SUFB)/disposable bronchoscopes during the ongoing pandemic have been issued by various professional pulmonary societies due to the risk of viral transmission when utilizing reusable, flexible bronchoscopes.

When it comes to treating infections caused by bronchoscopy, disposable bronchoscopes may be less expensive than RFB. They are also portable and easily accessible. Reusable, flexible bronchoscopes are still utilized for advanced diagnostic and therapeutic procedures due to their maneuverability, handling, image quality, angle of deflection, and larger channel size for passing ancillary instruments.

End-User Analysis

The Hospitals segment accounted for a significant share of the total market

Based on end-user, the market is classified into hospitals, diagnostic centers, and other end-users. In 2022, hospitals accounted for the largest revenue share. The high prevalence of respiratory conditions among patients admitted to hospitals for treatment or care is the key reason for this growth. This market is also expanding as a result of the high number of asthma and other lung diseases treated in emergency rooms. Additionally, a CAGR of 9.4% is anticipated for this market segment during the forecast period

Before endoscopy, patients prefer hospitals for surgeries; bronchoscopy patients must take a number of serious precautions. The skilled personnel present to perform the bronchoscopy is another major reason why the hospital segment leads.

Key Market Segments

Based on Product Type

• Rigid Bronchoscope
• Flexible Bronchoscope (Video, Fiberotrophic, and Hybrid)
• Other Product Types

Based on Usage

• Reusable Bronchoscope
• Disposable Bronchoscope

Based on End-User

• Hospitals
• Diagnostic Centers
• Other End-Users

Drivers

Rising geriatric population and increasing respiratory diseases

Lung structures and airways are impacted by chronic respiratory conditions. It impairs lung function in all ages. Health can be improved, and premature death can be avoided with early diagnosis and treatment. Although CRDs cannot be cured, treatment can alleviate symptoms and enhance the quality of life. Elderly patients should be diagnosed and treated right away due to the high prevalence of the disease and its complications.

Patients over the age of 65 were evaluated for the diagnostic value of flexible bronchoscopy (FB) findings. Globally, chronic respiratory diseases are a major problem. Chronic lung conditions and unidentified respiratory issues are treated in weekly outpatient clinics. Patients are quickly diagnosed and referred by skilled respiratory consultants.

Innovations in the technology of bronchoscopy devices

As of now, there are far advanced technologies regarding bronchoscopy diagnostics. Therefore, instead of using bronchoscopic procedures, pulmonologists used to refer patients to radiologists, surgeons, and medical oncologists. This is because of the bronchoscopy ecosystem, standards, demand, and technology. There will be more innovations in the coming years. As a result of these advancements, respiratory therapists (RTs) are now able to bring expertise in clinical, organizational, and scientific areas to this developing field. Diagnostic bronchoscopy has been improved by peripheral navigation, real-time ultrasound, and more recent bronchoscopes.

Biopsies performed by bronchoscopists have been enhanced by real-time visualization while avoiding vascular structures. Bronchoscopes can only enter the airways of the third or fourth generation. Except for ultrasound for proximal lesions, advanced bronchoscopy yields are limited by this challenge. There are now slimmer bronchoscopes with larger working channels, more angulation, better imaging, and the ability to visualize pathology.

Restraints

Risk of infection and cross-contamination following a bronchoscopy

In order to disinfect or sterilize microorganisms, reprocess bronchoscopes between patients and get rid of soil and other contaminants. Reusable devices are cleaned, disinfected, and sterilized during reprocessing. The flexible bronchoscope can spread infection from patient to patient if it is not cleaned properly.

Surface wiping and channel flushing are part of the pre-cleaning procedure to stop the blood, tissue, and other biological debris from drying out; inadequate hand-cleaning prior to HLD or sterilization; unclean channels; high-level disinfectant or detergent that has gone bad; Lack of adequate HLD drying, rinsing, and flushing. This situation prevents the market from expanding and results in the cross-contamination of diseases and infections among patients.

Opportunity

Government Initiatives in Developing Countries

Market expansion might result from government medical care spending and reimbursement system development. As respiratory issues rise, bronchoscope demand rises. There are 65 million individuals who have COPD, 3 million have died from it, and 1.8 million have lung cancer, as per the WHO.

Air contamination causes numerous respiratory issues that severely affect well-being, so respiratory health is most important. Poor air quality causes respiratory infections, emphysema, sensitivities, asthma, and COPD. The WHO recently proclaimed air pollution as the single biggest environmental threat to human well-being.

Trends

Rising preference toward single-use/disposable bronchoscope

Anesthetists use the single-use flexible bronchoscope in an intensive care unit (ICU) or perioperative setting because they perform at a higher level than reusable, flexible bronchoscopes and have the distinct advantage of a lower risk of infection because they are sterile. In several clinical settings, single-use flexible bronchoscopes are cost-effective and eliminate cross-contamination from reusable bronchoscopes. These are useful for finding diseases like lung cancer, COPD, tumors, and many others.

Bronchoscope market trends have witnessed an enormous surge in recent years. Due to increased prevalence of chronic obstructive pulmonary disease (COPD) and lung cancer, diagnostic and therapeutic procedures for both conditions has become more and more urgently required with that demand comes an ever-increasing requirement for diagnostic tools thus making bronchoscopes essential tools of healthcare professionals such as pulmonologists.

Regional Analysis

North America dominated the market with the largest share of 42.8%

The global market for bronchoscopes, in which North America holds the largest share, is anticipated to expand at a CAGR of 9.4% over the forecast period. The United States is anticipated to hold a 91.8% market share by value in North America due to factors such as an upsurge in hospitals, healthcare spending, healthcare infrastructure, an aging population, and a large patient population. Demand for bronchoscopes is also rising as favorable reimbursement scenarios in the United States are anticipated to persist. Due to a large number of well-established market players and rising lung cancer rates, North America leads the market.

During the forecast period, Asia-Pacific is anticipated to expand at the fastest CAGR of 10.3%. The market is being driven by mandatory health insurance, rising technology, rising healthcare costs, and an increasing number of global market players looking to meet these countries’ high unmet medical needs. By value, the Asia-Pacific bronchoscopes market is expected to grow by 20% in India. Demand for bronchoscopes in India is driven by the rising adoption of bronchoscopy, government spending on healthcare, and chronic pulmonary diseases.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

The increasing demand for products that can diagnose and treat a variety of lung conditions has resulted in a highly competitive market. The market is being driven by developments in the market and regular product approvals from regulatory authorities. Collaborations, mergers and acquisitions, new product launches, and partnerships are some of the most important tactics that major players use to improve their market position.

Listed below are some of the most prominent bronchoscopes industry players.

Market Key Players

• Teleflex Incorporated
• Olympus Corporation
• FUJIFILM Holdings Corporation
• Ambu A/S
• Karl Storz SE & Co. KG
• Boston Scientific Corporation
• Cogentix Medical, Inc.
• Richard Wolf GmbH
• Cook Medical.
• HOYA Corporation
• Other Key Players

Recent Developments

• In May 2022, Premier, Inc. and Olympus Corporation, a Japanese manufacturer of optics and reprography, entered into a group purchasing agreement for Premier, Inc.’s single-use bronchoscope portfolio in the Single-Use Visualization Devices category.

• In July 2022, Ambu Inc. announced that the FDA had granted 510(k) regulatory clearance to the family of single-use, sterile bronchoscopes known as Ambu aScopeTM 5 Broncho.

Report Scope